Preventing perinatal transmission of HIV: an evidence-based update for midwives.
This article presents an update on human immunodeficiency virus care in the United States, with an emphasis on care during pregnancy and strategies to prevent perinatal transmission. Common drug regimens are reviewed. Obstetric factors related to transmission, such as mode of delivery, also are discussed. Guidelines for collaboration between midwives and human immunodeficiency virus specialists are outlined.
Patchen
L
L
Washington Hospital Center, DC 20010-2965, USA.
Beal
M W
MW
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008880:Midwifery; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D011256:Pregnancy Outcome
D019380:Anti-HIV Agents